Ask AI
ProCE Banner Activity

Advances in Personalized TKI Therapy for CP-CML: Oncology Nursing Pocket Guide

PDF

This PDF resource serves as a point-of-care resource that provides up-to-date AE management guidance for nurses and their patients with CP-CML receiving approved TKI therapy. The downloadable pocket guide helps to quickly identify, grade, and manage AEs associated with TKI therapy in patients with CP-CML. It also ensures equitable communication with patients and the MDT on indications, dosage, and administration of approved TKIs, along with AE monitoring, and supportive care. 

Released: July 10, 2026

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation

Target Audience

This activity has been designed to meet the educational needs of oncology nurses and other healthcare professionals who care for patients with CML. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Support shared decision-making by educating patients with CP-CML about the latest clinical evidence and approvals for TKIs that are most likely to meet their treatment goals

  • Identify patients with CP-CML at risk for suboptimal adherence/persistence to their TKI therapy 

  • Apply evidence-based strategies for supportive care and dose optimization to manage TKI-related adverse events in patients with CP-CML

Financial Disclosures

Primary Author

Leilani (Hong) Lien, BSN, RN, PHN, TCTCN, has no relevant financial relationships to disclose.